Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF
While Zepbound (Tirzepatide) combines dual hormone action, Wegovy focuses on GLP-1 pathways alone
For researchers comparing GLP-1, dual-incretin, and multi-incretin pathway compounds, that level of control matters
Monitoring of symptoms helps in managing side effects effectively
The other drugs used for obesity, like Contrave, Qsymia, and orlistat, do not demonstrate as much weight loss
Understanding Semaglutide: A Key to Weight Management Ozempic and Wegovy contain semaglutide, a medication that mimics a natural hormone in your body, regulating blood sugar and appetite